Benzinga · Jun 30, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Friday.
The Dow traded up 0.93% to 34,439.75 while the NASDAQ rose 1.54% to 13,800.92. The S&P 500, also rose, gaining, 1.32% to 4,454.48.
Check This Out: Top 5 Tech And Telecom Stocks That Are Ticking Portfolio Bombs
Leading and Lagging Sectors
Information technology shares jumped by 1.7% on Friday.
In trading on Friday, real estate shares fell by 0.3%.
Top Headline
The total number of active U.S. oil rigs fell by 1 to 545 rigs this week, Baker Hughes Inc reported.
Equities Trading UP
Renalytix Plc (NASDAQ: RNLX) shares shot up 44% to $2.92 after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test.
Shares of Baudax Bio, Inc. (NASDAQ: BXRX) got a boost, shooting 123% to $1.16 after the company agreed to acquire TeraImmune in a stock-for-stock transaction.
Cyteir Therapeutics, Inc. (NASDAQ: CYT) shares were also up, gaining 38% to $2.65 after the company announced that it is discontinuing all development of CYT-0851, dissolving the company and liquidating its assets.
Equities Trading DOWN
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares dropped 26% to $1.2150 after the company provided an update concerning its marketing application for lanthanum dioxycarbonate for hyperphosphatemia in chronic kidney ...
Benzinga · Jun 30, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Friday.
The Dow traded up 0.62% to 34,333.42 while the NASDAQ rose 1.37% to 13,777.52. The S&P 500, also rose, gaining, 1.04% to 4,441.95.
Check This Out: Top 5 Tech And Telecom Stocks That Are Ticking Portfolio Bombs
Leading and Lagging Sectors
Information technology shares jumped by 1.7% on Friday.
In trading on Friday, real estate shares rose by just 0.2%.
Top Headline
The Core Personal Consumption Expenditure (PCE) price index, the Federal Reserve's preferred measure of inflation, rose 4.6% year-over-year in May 2023, slightly down from both the previous and expected 4.7%, the U.S. Bureau of Economic Analysis reported Friday.
Equities Trading UP
Renalytix Plc (NASDAQ: RNLX) shares shot up 33% to $2.69 after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test.
Shares of Baudax Bio, Inc. (NASDAQ: BXRX) got a boost, shooting 152% to $1.3138 after the company agreed to acquire TeraImmune in a stock-for-stock transaction.
Cyteir Therapeutics, Inc. (NASDAQ: CYT) shares were also up, gaining 37% to $2.63 after the company announced that it is discontinuing all development of CYT-0851, dissolving the company and liquidating its assets.
Equities Trading DOWN
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares dropped 24% to $1.26 ...
Benzinga · Feb 3, 2023
Upgrades
Goldman Sachs upgraded the previous rating for Align Technology Inc (NASDAQ:ALGN) from Sell to Neutral. For the fourth quarter, Align Tech had an EPS of $1.73, compared to year-ago quarter EPS of $2.83. At the moment, the stock has a 52-week-high of $552.00 and a 52-week-low of $172.05. Align Tech closed at $359.88 at the end of the last trading period.
According to CBRE, the prior rating for Boyd Gaming Corp (NYSE:BYD) was changed from Hold to Buy. For the fourth quarter, Boyd Gaming had an EPS of $1.72, compared to year-ago quarter EPS of $1.35. The current stock performance of Boyd Gaming shows a 52-week-high of $72.72 and a 52-week-low of $46.10. Moreover, at the end of the last trading period, the closing price was at $62.14.
Gordon Haskett upgraded the previous rating for Nordstrom Inc (NYSE:JWN) from Reduce to Hold. In the third quarter, Nordstrom showed an EPS of $0.20, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of $29.59 and a 52-week-low of $15.53. Nordstrom closed at $21.14 at the end of the last trading period.
For International Paper Co (NYSE:IP), UBS upgraded the previous rating of Sell to Neutral. For the fourth quarter, International Paper had an EPS of $0.87, compared to year-ago quarter EPS of $0.78. The current stock performance of International Paper shows a 52-week-high of $50.23 and a 52-week-low of $30.69. Moreover, at the end of the last trading period, the closing price was at $41.53.
According to Morgan Stanley, the prior rating for Neurocrine Biosciences Inc (NASDAQ:NBIX) was changed from Equal-Weight to Overweight. In the third quarter, Neurocrine Biosciences showed an EPS of $1.08, compared to $0.64 from the year-ago quarter. The current stock performance of Neurocrine Biosciences shows a 52-week-high of $129.29 and a 52-week-low of $75.25. Moreover, at the end of the last trading period, the closing price was at $108.00.
According to Morgan Stanley, the prior rating for Esperion Therapeutics Inc (NASDAQ:ESPR) was changed from Underweight to Equal-Weight. For the third quarter, Esperion Therapeutics had an EPS of $0.81, compared to year-ago quarter EPS of $2.62. The stock has a 52-week-high of $8.87 and a 52-week-low of $3.28. At the end of the last trading period, Esperion Therapeutics closed at $5.92.
For Erasca Inc (NASDAQ:ERAS), Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Erasca showed an EPS of $0.29, compared to $0.46 from the year-ago quarter. The current stock performance of Erasca shows a 52-week-high of $12.80 and a 52-week-low of $3.60. Moreover, at the end of the last trading period, the closing price was at $4.15.
For H.B. Fuller Co (NYSE:FUL), Citigroup upgraded the previous rating of Neutral to Buy. H.B. Fuller earned $1.04 in the fourth quarter, compared to $1.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $81.41 and a 52-week-low of $57.36. H.B. Fuller closed at $73.35 at the end of the last trading period.
Baird upgraded the previous rating for Cardinal Health Inc (NYSE:CAH) from Neutral to Outperform. Cardinal Health earned $1.32 in the second quarter, compared to $1.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $81.57 and a 52-week-low of $49.70. Cardinal Health closed at $76.28 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
For SLM Corp (NASDAQ:SLM), Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. For the fourth quarter, SLM had an EPS of $0.33, compared to year-ago quarter EPS of $1.05. At the moment, the stock has a 52-week-high of $20.75 and a 52-week-low of $13.72. SLM closed at $14.80 at the end of the last trading period.
For ConocoPhillips (NYSE:COP), Capital One downgraded the previous rating of Overweight to Equal-Weight. In the fourth quarter, ConocoPhillips showed an EPS of $2.71, compared to $2.27 from the year-ago quarter. The current stock performance of ConocoPhillips shows a 52-week-high of $138.49 and a 52-week-low of $78.30. Moreover, at the end of the last trading period, the closing price was at $111.30.
According to Sidoti & Co., the prior rating for Minerals Technologies Inc (NYSE:MTX) was changed from Buy to Neutral. For the fourth quarter, Minerals Technologies had an EPS of $0.67, compared to year-ago quarter EPS of $1.25. The current stock performance of Minerals Technologies shows a 52-week-high of $73.57 and a 52-week-low of $49.38. Moreover, at the end of the last trading period, the closing price was at $72.65.
HC Wainwright & Co. downgraded the previous rating for Vyant Bio Inc (NASDAQ:VYNT) from Buy to Neutral. Vyant Bio earned $0.62 in the third quarter, compared to $0.75 in the year-ago quarter. The stock has a 52-week-high of $9.85 and a 52-week-low of $0.66. At the end of the last trading period, Vyant Bio closed at $1.03.
Northland Capital Markets downgraded the previous rating for MACOM Technology Solutions Holdings Inc (NASDAQ:MTSI) from Outperform to Market Perform. For the first quarter, MACOM Technology Solns had an EPS of $0.81, compared to year-ago quarter EPS of $0.64. The stock has a 52-week-high of $72.64 and a 52-week-low of $42.85. At the end of the last trading period, MACOM Technology Solns closed at $66.52.
For Bill.com Holdings Inc (NYSE:BILL), BTIG downgraded the previous rating of Buy to Neutral. For the second quarter, Bill.com Holdings had an EPS of $0.42, compared to year-ago quarter EPS of $0.00. The stock has a 52-week-high of $262.17 and a 52-week-low of $89.87. At the end of the last trading period, Bill.com Holdings closed at $128.91.
For ...Full story available on Benzinga.com
